Why Invest in Arrive AI

Arrive AI is headed for the Nasdaq (Ticker: ARAI)

Now are the final weeks to invest at pre-public pricing in a company with a first-mover advantage at bringing smart, autonomous, AI-powered technology to life.

Founder Dan O'Toole beat Amazon to a first-position drone docking patent in 2014. Today, Arrive AI has crowdfunded more than $11 million and is installing the first of its Arrive Points™ in pilot programs across the country.

"I wanted to get in on the ground floor of this life-changing opportunity. I had a chance to invest in Marvel Comics before Disney bought them out, and I didn’t want to miss out this time."

- Paul Sheppard, Arrive AI Investor

Arrive AI is not the drone or robot, it is a smart, autonomous and AI-powered delivery network anchored by its flagship product, the Arrive Point™

Arrive Points™ work seamlessly with drones, robots and human carriers to build a robust platform that makes life easier, our earth cleaner and companies more efficient.

Arrive AI is helping improve operations such as medicine courier services by providing a secure access point that is climate-assisted and maintains a strong chain of custody. The ability to provide this asynchronous, secure delivery provides patient convenience, theft prevention, and cost savings for pharmacies, courier services, logistics carriers and more.

Now, Arrive AI is poised to hit the Nasdaq; a dream by Chairman and CEO Dan O'Toole that will soon be realized.

"Everyone is either even or up. Not one person has lost money with this investment and now we’re inches away from being listed on the Nasdaq and providing the liquidity to these investors that I’ve promised from the beginning."

Fast Facts:

Filed company's registration statement with the SEC in preparation for a Nasdaq direct listing
$375 million independent valuation
The pharmaceutical logistics market alone is projected to reach $144 billion by 2030, and Arrive AI’s cutting-edge technology is poised to capture a significant share
First-mover advantage in a rapidly expanding market
Proven technology with established partnerships in high-growth industries
A robust first-position patent portfolio both in the U.S. and internationally

O'Toole turned down three credible acquisition offers worth hundreds of millions of dollars stating he’s not taking the short money!

“Only 3/10s of 1% of any crowdfunded company has ever gone public or had a major liquidity event. Out of those that do go public, only 3% of them have failed. We are hopeful and confident that we can be in that successful 97%.

Our promise from day 1 has been to deliver an avenue where people can realize the ROI that they’ve gained from their investment in Arrive AI. And we are so close. That is the promise of investing in any company. Paper gains are just that - but to have the opportunity to transact and harvest in those gains is a game changer.”

- Dan O'Toole, Arrive AI Chairman and CEO

Nasdaq Ready Growth

Positioned for rapid expansion, with an imminent Nasdaq debut in Q1 2025

Innovative Technology

Proprietary AI-powered smart mailbox ensuring secure, climate-assisted deliveries.

High-Growth Market

Addressing a critical gap in the $144 billion pharmaceutical logistics market.

Proven Traction

Successful partnerships with pharmaceutical couriers, reducing delivery errors and improving efficiency

Experienced Leadership

Led by industry veterans with a track record of success in AI, logistics, and healthcare solutions

Sustainability Impact

Reducing waste and delivery errors, contributing to greener, more efficient logistics systems

First-Mover Advantage

Establishing leadership in an emerging market with few competitors in the AI-powered smart mailbox sector

Scalable Solution

Designed to integrate seamlessly across industries, with potential applications in healthcare, retail, and more

Cautionary Note Regarding Forward Looking Statements

The statements of Arrive AI’s business or management in this post or on our website may contain or may contain “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. In this context, forward-looking statements mean statements (including statements related to the closing, and the anticipated benefits to the Company, of the private placement described herein) related to future events, which may impact our expected future business and financial performance, and often contain words such as “expects”, “anticipates”, “intends”, “plans”, “believes”, “potential”, “will”, “should”, “could”, “would” ,”optimistic” or “may” and other words of similar meaning. These forward-looking statements are based on information available to us as of the date of this post and represent management’s current views and assumptions. Forward-looking statements are not guarantees of future performance, events or results and involve significant known and unknown risks, uncertainties and other factors, which may be beyond our control. Readers are cautioned not to place undue reliance on these forward-looking statements, which apply only as of the date of this post. Potential investors should review Arrive’s Registration Statement for more complete information, including the risk factors that may affect future results, which are available for review at www.sec.gov. Accordingly, forward-looking statements should not be relied upon as a predictor of actual results. We do not undertake to update our forward-looking statements to reflect events or circumstances that may arise after the date of this post, except as required by law. Investors may also request a copy of the Registration Statement by calling (463) 270-0092 or emailing Cheryl Reed at cheryl@arriveai.com.